These medicines include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Byetta, Bydureon), and lixisenatide (Lyxumia)
Image Credit: VectorMine / Shutterstock In a recent review published in the British Journal of Pharmacology , the authors reviewed how glucagon-like peptide 1 receptor (GLP-1) agonists may reduce alcohol and drug-seeking behaviors and evaluated their potential as treatments for addictive disorders
Both including and excluding these additional firms yielded the same percentage point estimates both last year and this year: 65% in 2024 and 61% in 2025
Our ability to enter a new market, build a locally credible program, deliver access to first-of-its-kind medical treatment, and generate real impact at scale is what sets us apart." "Generics have always played a critical role in expanding access to medicines that change lives, said Dr
The average user might end up with a battery that fails to meet that rating